A vast number of genes of unknown function threaten to clog drug discovery pipelines. To develop therapeutic products from novel genomic targets, it will be necessary to correlate biology with gene sequence information. Industrialized mouse reverse genetics is being used to determine gene function i
Searching for drug targets in microbial genomes
โ Scribed by Michael Y Galperin; Eugene V Koonin
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 279 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0958-1669
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Signaling complexes and networks are being intensely studied in an attempt to discover pathways that are amenable to therapeutic intervention. A challenge in this search is to understand the effect that the modulation of a target will have on the overall function of a cell and its surro
Automated fluorescent sequencers have now generated full and partial sequences of several eukaryotic genomes. How can we best use this information to discover new drugs? One important tool is mRNA expression profiling with DNA arrays. Large-scale high-density DNA arrays can be created for hybridizat
The mouse has become the premier mammalian system for the identification of the genetic basis of both mono-and oligogenic disorders, as well as the understanding of complex diseases with gene-gene and gene-environment interactions. The similarity between human and mouse genetic disease is sometimes
The exponentially growing collection of genomic sequence information, the high-throughput analysis of expression products, and the ability to order this information using advanced bioinformatics are expected to affect biotechnology and life sciences in a profound and unprecedented way. These develop